R. Geller

430 total citations
7 papers, 344 citations indexed

About

R. Geller is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, R. Geller has authored 7 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Infectious Diseases. Recurrent topics in R. Geller's work include Hematopoietic Stem Cell Transplantation (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). R. Geller is often cited by papers focused on Hematopoietic Stem Cell Transplantation (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). R. Geller collaborates with scholars based in United States and Japan. R. Geller's co-authors include S P Dix, C. Gilmore, Derek J. Falconer, John R. Wingard, Frederick S. Nolte, Tanya Parkinson, Vogelsang Gb, GW Santos, Judith E. Karp and G J Mufti and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R. Geller

5 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Geller United States	4	150	141	106	89	46	7	344
Daniela Onofrillo Italy	7	54 0.4×	59 0.4×	51 0.5×	26 0.3×	59 1.3×	16	188
Mitra Hanisch Germany	5	175 1.2×	26 0.2×	186 1.8×	115 1.3×	38 0.8×	5	314
Sandro Silva‐Gomes Portugal	10	71 0.5×	62 0.4×	93 0.9×	101 1.1×	157 3.4×	11	369
John Weiss United States	11	92 0.6×	118 0.8×	44 0.4×	21 0.2×	120 2.6×	18	441
Pérsio Roxo-Júnior Brazil	10	37 0.2×	34 0.2×	53 0.5×	180 2.0×	56 1.2×	31	342
James M. Conroy United States	11	64 0.4×	38 0.3×	35 0.3×	46 0.5×	112 2.4×	16	335
Christopher Molloy United Kingdom	9	85 0.6×	33 0.2×	39 0.4×	78 0.9×	126 2.7×	10	327
Adam J. DiPippo United States	10	221 1.5×	44 0.3×	180 1.7×	11 0.1×	44 1.0×	23	352
Ingvill Purr Germany	5	70 0.5×	18 0.1×	139 1.3×	125 1.4×	37 0.8×	6	349
Ian Storie United Kingdom	10	58 0.4×	59 0.4×	44 0.4×	116 1.3×	84 1.8×	12	354

Countries citing papers authored by R. Geller

Since Specialization

Citations

This map shows the geographic impact of R. Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Geller more than expected).

Fields of papers citing papers by R. Geller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Geller. The network helps show where R. Geller may publish in the future.

Co-authorship network of co-authors of R. Geller

This figure shows the co-authorship network connecting the top 25 collaborators of R. Geller. A scholar is included among the top collaborators of R. Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Geller. R. Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Petro, Daniel P., et al.. (2025). P2.06.11 Factors Impacting Receiving EGFR Test Results Before Initial Treatment Among Stage Iv Non-Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 20(10). S290–S291.

2.

Shah, Neal, Matthew T. Campbell, Shifeng Mao, et al.. (2023). 1889P Phase Ib/II study of batiraxcept (BT, AVB-S6-500, an AXL pathway inhibitor) in combination with cabozantinib (cabo) in patients with advanced clear cell renal cell carcinoma (ccRCC) who failed first-line (1L) therapy. Annals of Oncology. 34. S1016–S1017.

3.

Geller, R., et al.. (2009). Chronic fatigue syndrome and complement activation: Table 1. BMJ Case Reports. 2009. bcr0820080819–bcr0820080819. 1 indexed citations

4.

Karp, Judith E., David A. Rizzieri, Norbert Vey, et al.. (2006). Cloretazine is an effective induction therapy in elderly patients (pts) with poor-risk de novo AML. Journal of Clinical Oncology. 24(18_suppl). 6512–6512. 5 indexed citations

5.

Nolte, Frederick S., Tanya Parkinson, Derek J. Falconer, et al.. (1997). Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrobial Agents and Chemotherapy. 41(1). 196–199. 166 indexed citations

6.

Geller, R., et al.. (1989). INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION. The Lancet. 333(8641). 754–757. 163 indexed citations

7.

Gb, Vogelsang, et al.. (1989). Induction of autologous graft-versus-host disease.. PubMed. 21(1 Pt 3). 2997–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact